BusinessNovo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema SetbackBy Riza DagocAug 5, 2026, 8:59 AM UTC
HealthNew Mexico Measles Outbreak Cost Reached $5.4 Million, Study FindsBy Riza DagocAug 4, 2026, 3:23 AM UTC
BusinessNovo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug RaceBy Riza DagocAug 3, 2026, 6:02 AM UTC
BusinessAstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 BillionBy Riza DagocAug 3, 2026, 12:55 AM UTC
Insights & Views3 clinical-grade skincare creams you really shouldn’t buy onlineBy Lauren CortisJul 30, 2026, 7:38 AM UTC
BusinessGSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug PipelineBy Riza DagocJul 29, 2026, 4:11 AM UTC
BusinessAstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 OutlookBy Riza DagocJul 27, 2026, 9:02 AM UTC
HealthFDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to RiseBy Riza DagocJul 23, 2026, 1:23 AM UTC
